Ortho-McNeil Pharmaceutical, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 21678
 
  
 
C07D HETEROCYCLIC COMPOUNDS 14051
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 37130
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3317
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 32108
 
  
 
C07K PEPTIDES 28108
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1481
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 14124
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 12113
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1089

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8497373 Phosphonic acid compounds as inhibitors of serine proteasesMay 15, 12Jul 30, 13[A61K, C07F, C07D]
8304430 Phosphonic acid compounds as inhibitors of serine proteasesDec 20, 10Nov 06, 12[A61K, C07F]
8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsOct 24, 07Oct 02, 12[A61K]
8247599 Phosphonic acid compounds as inhibitors of serine proteasesOct 24, 08Aug 21, 12[C07F]
8212039 Phosphonic acid compounds as inhibitors of serine proteasesDec 20, 10Jul 03, 12[A61K, C07F]
8207338 Phosphonic acid compounds as inhibitors of serine proteasesDec 20, 10Jun 26, 12[A61K, C07F]
8198440 Phosphonic acid compounds as inhibitors of serine proteasesOct 24, 08Jun 12, 12[A61K, C07F, C07D]
8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsOct 24, 07May 22, 12[A61K]
8178673 Phosphonic acid compounds as inhibitors of serine proteasesOct 24, 08May 15, 12[C07F]
8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseOct 06, 10Mar 13, 12[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8609888 Phosphonic acid compounds as inhibitors of serine proteasesExpiredJul 17, 12Dec 17, 13[A61K, C07F]
2013/0230,459 RADIOLABELLED mGluR2 PET LIGANDSAbandonedNov 08, 11Sep 05, 13[A61K, C07D, G01N, C07B]
8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsExpiredJul 13, 10Aug 06, 13[A61K, C07D]
7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredNov 16, 06Jul 13, 10[A61K]
7557244 Substituted biphenyl carboxylic acids and derivatives thereofExpiredApr 20, 07Jul 07, 09[A01N, C07D, C07C]
2009/0170,759 NEUROPROTECTIVE PEPTIDESAbandonedJul 11, 07Jul 02, 09[A61K, C12N]
7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredJun 29, 05Dec 23, 08[A61K]
7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptorsExpiredJan 18, 06Jul 15, 08[A01N]
7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulatorsExpiredFeb 01, 06May 20, 08[A61K]
7354742 Method for generating amplified RNAExpiredFeb 22, 02Apr 08, 08[C12P]
7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsExpiredJun 29, 05Mar 18, 08[A61K]
7329654 Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulatorsExpiredDec 02, 02Feb 12, 08[A61P]
7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsExpiredNov 04, 02Jan 15, 08[A61K]
7265139 RXR activating moleculesExpiredMar 08, 02Sep 04, 07[C07D]
7226940 Substituted heterocycles for the treatment of diabetes and other diseasesExpiredAug 24, 05Jun 05, 07[A61K]
2007/0098,734 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseAbandonedOct 13, 06May 03, 07[A61K, C12N]
7196108 Bicyclic heterocycles for the treatment of diabetes and other diseasesExpiredMar 06, 03Mar 27, 07[A61K]
2007/0054,888 NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTSAbandonedNov 02, 06Mar 08, 07[A61K, C07D]
7172900 Isolated CD8.sup.+T lymphocytes specifically cytotoxic for a disease causing target cellWithdrawnMay 13, 02Feb 06, 07[C12N]
7153837 Agent for protection of retinal neuronsExpiredJun 14, 02Dec 26, 06[A01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.